Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults.
Durando P, Fenoglio D, Boschini A, Ansaldi F, Icardi G, Sticchi L, Renzoni A, Fabbri P, Ferrera A, Parodi A, Bruzzone B, Gabutti G, Podda A, Del Giudice G, Fragapane E, Indiveri F, Crovari P, Gasparini R.
Durando P, et al. Among authors: ansaldi f.
Clin Vaccine Immunol. 2008 Feb;15(2):253-9. doi: 10.1128/CVI.00316-07. Epub 2007 Nov 14.
Clin Vaccine Immunol. 2008.
PMID: 18003811
Free PMC article.
Clinical Trial.